Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 15,876 shares at $51.12 ($812K) on 2023-11-20, disclosed to the SEC on 2023-11-22.
Scheduled sale ($812k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.12 | 7,876 | $403K | 49.6% |
| 2 | $51.12 | 7,876 | $403K | 49.6% |
| 3 | $51.95 | 124 | $6K | 0.8% |
| Total | $51.13 avg | 15,876 | $812K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |